Ocio, E. M., Fernández-Lázaro, D., San-Segundo, L., López Corral, L., Corchete, L. A., Gutiérrez, N. C., . . . San-Miguel, J. F. (2014). In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.
Citación estilo ChicagoOcio, E M., et al. In Vivo Murine Model of Acquired Resistance in Myeloma Reveals Differential Mechanisms for Lenalidomide and Pomalidomide in Combination With Dexamethasone. 2014.
Cita MLAOcio, E M., et al. In Vivo Murine Model of Acquired Resistance in Myeloma Reveals Differential Mechanisms for Lenalidomide and Pomalidomide in Combination With Dexamethasone. 2014.
Precaución: Estas citas no son 100% exactas.